PADCEV ~ enfortumab vedotin-eifv ~ SEPT 29th ~ Don't miss it!

YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAM A program on an FDA-approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and a platinum- containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.

PRESENTER Bethany Mooney, RNP Medical Oncology Nurse Practitioner Penn Medicine Philadelphia, PA

LOCATION Register in advance for this meeting: Link: Meeting Registration After registering, you will receive a confirmation email containing information about joining the meeting.

Kindly Reply by 09/22/2020 In the RSVP, please include your Name, Contact Information, Organization, and Specialty.